Globus Medical, Inc.

GMEDNYSEHealthcare● Active

$80.00

+$0.00(+0.00%)

Market Cap$10.8B

P/E Ratio—

52W High$101.4

52W Low$51.79

Avg Volume1.4M

Open$80.06

Beta0.95

Free Cash Flow Financials Revenue

Globus Medical, Inc. (GMED) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

GMED · free cash flow · updated Jun 8, 2026

Core FCF metrics

GMED · FCF · TTM · margin & CAGR

Free cash flow was $588.8M for FY2025 (fiscal year ending 2025-12-31), up 45.3% year-over-year The FCF margin was 20.0%. Five-year CAGR stands at +34.2%.

FY2025 Free Cash Flow$588.8M▲ +45.3% YoY

Trailing 12M (TTM)$605.3Mtrailing 4 quarters sum

FCF Margin20.0%$588.8M ÷ revenue

3-Year CAGR+78.0%FY2022 → FY2025

5-Year CAGR+34.2%FY2020 → FY2025

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

GMED · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$753.4M(165M)$588.8M▲ +45.3%20.0%

FY2024$520.6M(115M)$405.2M▲ +145.2%16.1%

FY2023$243.5M(78M)$165.2M▲ +58.2%10.5%

FY2022$178.5M(74M)$104.4M▼ 52.4%10.2%

FY2021$276.3M(57M)$219.4M▲ +62.3%22.9%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

GMED · P/FCF · FCF yield · FCF per share

Globus Medical, Inc. (GMED) trades at a FCF yield of 5.61% and a price-to-free-cash-flow ratio of 17.9x. FCF per share stands at $4.48, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

5.61%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$4.48

TTM FCF ÷ Shares Outstanding

Price / FCF

x17.9

Share Price ÷ FCF per Share

EV / FCF (TTM)

x17.1

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

GMED · cash flow statement · operating / investing / financing

For FY2025, Globus Medical, Inc. generated $753.4M in operating cash flow and spent 165M in capital expenditures, yielding $588.8M in free cash flow.

Operating Activities

+$753.4M

Cash from core business operations

2025-12-31

Investing Activities

−$355.0M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

−$679.2M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF ($753.4M) − |CapEx| (165M) = FCF ($588.8M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

GMED vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Globus Medical, Inc.YOU

GMED

$588.8M+45.3%20.0%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Globus Medical, Inc. (GMED) reported free cash flow of $588.8M for FY2025 (fiscal year ending 2025-12-31), up 45.3% year-over-year. The FCF margin was 20.0%.

Based on available data, Globus Medical, Inc. has maintained positive free cash flow for at least 15 fiscal year(s). FCF peaked at $588.8M in FY2025. The 5-year CAGR stands at +34.2%.

Globus Medical, Inc.'s FCF yield is 5.61% and price-to-FCF ratio is 17.9x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

GMED free cash flow · 8 questions

Globus Medical, Inc. free cash flow was $588.8M for FY2025, up 45.3% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $605.3M.

GMED free cash flowGMED FCFGMED FCF 2025GMED free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Globus Medical, Inc. · Globus Medical, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026